Nabriva

Nabriva Therapeutics operates as a biopharmaceutical company, discovers and develops of antibiotics.

Business Model:

Revenue: $35.6M

Employees: 51-200

Rankings

Detailed Nabriva Information

Geographic Data

Nabriva headquarters map

Address: 25-28 North Wall Quay

City: Dublin

State: county dublin

Zip:

Country: IE

Financial Info

Stage:

post ipo equity

Raised Last:

$25M

Raised Total:

$212M

Metrics

4,830,619Website Global Rank

1,724Website Monthly Traffic

Twitter Followers

Description

Nabriva Therapeutics operates as a biopharmaceutical company, discovers and develops of antibiotics.

Contact Phone:

Contact Email:

Nabriva went public on 9/18/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
9/18/2015

Ticker Symbol:
NBRV

IPO Price:
$10.25/share

Amount Raised:
$92M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2016 Post-IPO Equity $21M
9/2007 Venture Round 1 $56M Phase4 Ventures
Phase4 Ventures
5/2010 Series B $22M Wellcome Trust
Novartis Venture Fund
Global Life Science Ventures
6/2011 Venture Round 1 $1.2M Arax Capital Partners
9/2015 IPO $92M
4/2015 Series B $98M Vivo Capital
OrbiMed
EcoR1 Capital LLC
HBM healthcare
Phase4 Partners
Wellcome Trust
Global Life Science Ventures
12/2018 Post-IPO Debt 2 $75M Armentum Partners
Hercules Capital
Armentum Partners
Hercules Capital
3/2021 Post-IPO Equity $25.4M
12/2014 Venture Round 1 $1.8M Arax Capital Partners
12/2010 Venture Round 1 $3.4M Arax Capital Partners
4/2015 Series B $0 Novartis Venture Fund
GLS Ventures
EcoR1 Capital
Wellcome Trust
HBM Healthcare Investments AG
OrbiMed
Phase4 Partners
Vivo Capital
OrbiMed
Vivo Capital
Boxer Capital
Novartis Venture Fund
GLS Ventures
EcoR1 Capital
Wellcome Trust
HBM Healthcare Investments AG
OrbiMed
Phase4 Partners
Vivo Capital
OrbiMed
Vivo Capital
Boxer Capital
10/2009 Venture Round $0 GLS Ventures
HBM Partners
Novartis Venture Fund
Phase4 Partners
Wellcome Trust
GLS Ventures
HBM Partners
Novartis Venture Fund
Phase4 Partners
Wellcome Trust
4/2015 Series B 9 $120M Novartis Venture Fund
GLS Ventures
EcoR1 Capital
Wellcome Trust
HBM Healthcare Investments AG
OrbiMed
Phase4 Partners
Vivo Capital
OrbiMed
Vivo Capital
Novartis Venture Fund
GLS Ventures
EcoR1 Capital
Wellcome Trust
HBM Healthcare Investments AG
OrbiMed
Phase4 Partners
Vivo Capital
OrbiMed
Vivo Capital
10/2009 Venture Round 5 $22.1M
Announced Date Name Price
7/2018 Zavante Therapeutics

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research